Home » Topics » Conferences

Conferences
RSS

OVA-IL-18 fusion DNA as a novel immunotherapeutic for asthma

April 21, 1999

FASEB presentation for PD-159879, an MMP inhibitor with potent antiinflammatory activity

April 21, 1999

SQ-885: a specific angiogenesis inhibitor and integrin antagonist

April 21, 1999

Immunomedics clones RNase and prepares RNase-containing anticancer fusion protein

April 21, 1999

Cell proliferation induction (CPI): a novel approach to wound healing

April 21, 1999

Rodent and early human studies support feasibility of transcutaneous immunization

April 21, 1999

Targretin as novel therapy for refractory breast cancer: preclinical studies

April 21, 1999

Angiotensin immunization as an immunotherapeutic approach to hypertension

April 21, 1999

AACR news: squalamine evaluated for activity in prostate and lung cancer models

April 20, 1999

Potent and long-lasting GnRH antagonist presented by Ferring

April 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...